Ye Hui-Nan, Liu Xiao-Yan, Qin Bao-Li
Department of Gastroenterology, Cancer Hospital of China Medical University; Cancer Hospital of Dalian University of Technology; Liaoning Cancer Hospital & Institute, Shenyang 110801, Liaoning Province, China.
World J Gastrointest Oncol. 2023 Jan 15;15(1):69-75. doi: 10.4251/wjgo.v15.i1.69.
Gastric cancer (GC) is a malignant tumor originating from the gastric epithelium, and its incidence and mortality rates rank third among all malignant tumors worldwide. It is also one of the most common cancers in China and is treated predominantly by Western medicine in clinical practice. However, with the advancements in medical technology and informatics, the values of traditional Chinese medicine (TCM) in preventing and treating GC and improving prognosis have increasingly been recognized. According to TCM, clinical manifestations of GC can be divided into Yege (dysphagia), regurgitation, stomach pain, and Zhengxia (abdominal mass). Due to the unbalanced distribution of health care resources in China, most GC patients already have progressive or advanced-stage disease at the first diagnosis. As a result, most GC patients have poor physical function, and surgery or chemotherapy alone will aggravate the impairment to the immune function and seriously affect the quality of life. In contrast, TCM therapies have shown promising efficacy in the management of these patients. Here we review the role of the integrated TCM and Western medicine in treating advanced GC.
胃癌（GC）是一种起源于胃上皮的恶性肿瘤，其发病率和死亡率在全球所有恶性肿瘤中排名第三。它也是中国最常见的癌症之一，在临床实践中主要采用西医治疗。然而，随着医学技术和信息学的进步，中医在预防和治疗胃癌以及改善预后方面的价值越来越受到认可。根据中医理论，胃癌的临床表现可分为噎膈（吞咽困难）、反胃、胃脘痛和症瘕（腹部肿块）。由于中国医疗资源分布不均衡，大多数胃癌患者在首次诊断时已处于进展期或晚期。因此，大多数胃癌患者身体功能较差，单纯手术或化疗会加重免疫功能损害，严重影响生活质量。相比之下，中医治疗在这些患者的管理中显示出了有前景的疗效。在此，我们综述中西医结合在治疗晚期胃癌中的作用。
